Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma☆
暂无分享,去创建一个
Yu Cheng | Yu Han | Matthew V. Tirrell | Brenda Auffinger | Maciej S. Lesniak | Eun Ji Chung | Y. Cheng | E. J. Chung | M. Tirrell | K. Nord | D. Wainwright | M. Lesniak | R. Morshed | Yu Han | Kathryn Nord | B. Auffinger | Michelle L Wegscheid | Ramin Morshed | Michelle L. Wegscheid | Derek A. Wainwright | R. Morshed
[1] Supriya Shidhaye,et al. Advances in polymeric micelles for drug delivery and tumor targeting. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[2] Yaping Li,et al. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.
[3] Wei Lu,et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[4] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[5] Quanyin Hu,et al. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. , 2013, Biomaterials.
[6] R. Ádány,et al. Fibrin deposition in primary and metastatic human brain tumours. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[7] Ruth Nussinov,et al. Nanoparticle-induced vascular blockade in human prostate cancer. , 2010, Blood.
[8] Susan M. Chang,et al. A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants , 2001, Cancer.
[9] Lai Yeng Lee,et al. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. , 2009, Biomaterials.
[10] Erkki Ruoslahti,et al. Targeting atherosclerosis by using modular, multifunctional micelles , 2009, Proceedings of the National Academy of Sciences.
[11] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[12] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[13] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[14] P. Choyke,et al. New strategies for fluorescent probe design in medical diagnostic imaging. , 2010, Chemical reviews.
[15] W. Pardridge. Drug Targeting to the Brain , 2007, Pharmaceutical Research.
[16] Hamidreza Ghandehari,et al. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] T. Budinger,et al. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[18] Kofi-Buaku Atsina,et al. Novel Delivery Strategies for Glioblastoma , 2012, Cancer journal.
[19] R. Stupp,et al. Current concepts and management of glioblastoma , 2011, Annals of neurology.
[20] H. Dvorak,et al. Regulation of extravascular coagulation by microvascular permeability. , 1985, Science.
[21] E. Ruoslahti,et al. Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[22] Quanyin Hu,et al. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. , 2013, Biomaterials.
[23] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[24] A. Kabanov,et al. Novel Nanomaterials for Clinical Neuroscience , 2008, Journal of Neuroimmune Pharmacology.
[25] S. Piantadosi,et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.
[26] E. London,et al. Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge. , 1984, Analytical biochemistry.
[27] V. Torchilin,et al. Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.
[28] H. Gendelman,et al. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. , 2007, Progress in polymer science.
[29] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[30] Linyin Feng,et al. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[31] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[32] Michael J Sailor,et al. Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.
[33] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[34] Xiaoling Fang,et al. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. , 2012, Biomaterials.
[35] Y. Kuo,et al. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. , 2011, Biomaterials.